Vitabakt gl. drops 0.05% 10ml

Release form, composition and packaging

?

Eye drops in the form of a transparent, colorless or slightly yellowish solution.

1 ml

picloxidine dihydrochloride 500 mcg,

which corresponds to the content of picloxidine 434 μg

dextrose (glucose) anhydrous - 50 mg, polysorbate 80 - 0.25 mg, purified water - up to 1 ml.

10 ml - polyethylene dropper bottles (1) - cardboard packs.

pharmachologic effect

The drug with antimicrobial action, a derivative of biguanides.

Active against Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Eberthella typhosa, Klebsiella pneumoniae, Proteus vulgaris, Shigella dysenteriae, Bacillus subtilis, Chlamydia trachomatis

some viruses and fungi.

Pharmacokinetics

When applied topically, the systemic absorption of picloxidine is low.

Indications for use

Adults and children from 0 years old: - bacterial infections of the anterior part of the eye

- dacryocystitis

- prevention of infectious complications in the postoperative period after surgical interventions in the anterior part of the eye.

Contraindications for use

- hypersensitivity to drug components.

Dosage regimen

When treating bacterial infections, the drug is instilled into the conjunctival sac 1 drop 2-6 times / day. The duration of treatment is 10 days, the feasibility and necessity of increasing the duration of treatment for more than 10 days is determined by the doctor. In the postoperative period, the drug is instilled into the conjunctival sac 1 drop 3-4 times / day. For the prevention of postoperative complications (preoperative preparation), 1-2 drops of the drug are instilled into the conjunctival sac immediately before surgery. Terms of use of the drug Vitabact® eye drops are produced in a sealed polyethylene bottle with a dropper, no pipette is required for their instillation. To open the bottle, it is necessary to screw the cap all the way down, while the spike on its inner side should pierce the dropper.To instill eye drops, it is necessary to tilt the patient's head back a little, the patient's gaze should be directed upward. The drug is instilled into the lower conjunctival sac by gently pulling the lower eyelid. To prevent contamination of the drug solution during instillation, patients should avoid contact of the dropper tip with the eye and skin.

Overdose

There are no data on an overdose of Vitabact®.

Side effect

Rarely: allergic reactions in the form of conjunctival hyperemia.

Drug interactions

If it is necessary to instill several drugs into the conjunctival sac, the drugs should be used separately with an interval of at least 15 minutes.

Application during pregnancy and lactation

Since the use of the drug during pregnancy and lactation has not been studied, Vitabact® is not recommended for pregnant and lactating women.

Special instructions Do not use Vitabact® eye drops for subconjunctival injections or injected into the anterior chamber of the eye.

Vitabact® eye drops do not change the color of contact lenses (including soft hydrophilic ones), however, in case of infectious eye diseases, wearing contact lenses is contraindicated.

With a decrease in the clarity of vision during treatment with the drug, patients should refuse to drive vehicles and work with mechanisms.

Influence on the ability to drive vehicles and control mechanisms With a decrease in vision clarity during treatment with the drug, patients should refuse to drive vehicles and work with mechanisms.

Name ENG

VITABACT

Clinical and pharmacological group

Antiseptic for topical use in ophthalmology

ATX code

Picloxydine

Dosage

0.05% x 10ml

Structure

Eye drops 0.05% in the form of a transparent, colorless or slightly yellowish solution.

1 ml: picloxidine dihydrochloride 500 μg, which corresponds to the content of picloxidine 434 μg.

Excipients: anhydrous dextrose (glucose) - 50 mg, polysorbate 80 - 0.25 mg, purified water - up to 1 ml.

Indications

Adults and children from 0 years old.

Bacterial infections of the anterior part of the eye

dacryocystitis

prevention of infectious complications in the postoperative period after surgical

interventions in the anterior region of the eye.

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 2 years

after opening - 1 month

Contraindications

Increased individual sensitivity to drug components.

Since the use of the drug during pregnancy and lactation has not been studied, Vitabact® is not recommended for pregnant and lactating women.

INN / Active ingredient

picloxidine dihydrochloride

Specifications

Category

Inflammation and infections

Scope of the drug

Eyes

Release form

Drops

Manufacturer country

France

Package quantity, pcs

one

Way of introduction

Into the conjunctival sac

Vacation conditions

Without recipe

Shelf life after opening

one

Volume, ml.

10 ml

Brand name

Laboratoires ThE

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Polyethylene dropper bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antimicrobial agent

Anatomical and therapeutic characteristics

S01AX16 Picloxidine

Dosage form

Eye drops

Expiration date in days

730

Package weight, g

twenty

Mode of application

:

When treating bacterial infections, the drug is instilled into the conjunctival sac 1 drop 2-6 times / day. The duration of treatment is 10 days, the expediency and necessity of increasing the duration of treatment for more than 10 days is determined by the doctor. < br> < br> In the postoperative period, the drug is instilled into the conjunctival sac, 1 drop 3-4 times / day. < br> < br> For prevention postoperative complications (preoperative preparation), 1-2 drops of the drug are instilled into the conjunctival sac immediately before surgery. no pipette required. To open the bottle, screw the cap all the way down,while the thorn on its inner side should pierce the dropper. < br> < br> To instill eye drops, the patient's head should be tilted back a little, the patient's gaze should be directed upward. The drug is instilled into the lower conjunctival sac, gently pulling the lower eyelid. < br> < br> To prevent contamination of the drug solution during instillation, patients should avoid contact of the dropper tip with the eye and skin.To prevent contamination of the drug solution during instillation, patients should avoid contact of the dropper tip with the eye and skin.To prevent contamination of the drug solution during instillation, patients should avoid contact of the dropper tip with the eye and skin.

Dosage (volume) of the substance in the preparation

:

picloxidine dihydrochloride - 0.500 mg

which corresponds to 0.434 mg of picloxidine

Information on technical characteristics, delivery set, country of manufacture